使用自动化胰岛素输注改善血液透析的 1 型糖尿病和终末期肾病患者血糖控制的病例系列研究。
Case series of using automated insulin delivery to improve glycaemic control in people with type 1 diabetes and end stage kidney disease on haemodialysis.
机构信息
Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, UK.
出版信息
Diabetes Res Clin Pract. 2024 Nov;217:111800. doi: 10.1016/j.diabres.2024.111800. Epub 2024 Aug 14.
Automated insulin delivery (AID) in people with type 1 diabetes (pwT1D) and end-stage kidney disease (ESKD) on haemodialysis (HD) has not been reported previously. We describe practical considerations and our findings in four pwT1D on HD for ESKD where AID was safely implemented, with significant improvements in time in range.
在接受血液透析（HD）治疗的终末期肾病（ESKD）的 1 型糖尿病（T1D）患者（pwT1D）中，自动化胰岛素输注（AID）此前尚未有报道。我们描述了在 4 例接受 HD 治疗 ESKD 的 pwT1D 中实施 AID 的实际注意事项和研究结果，该方法安全有效，可显著提高血糖达标时间。
Zotero 插件